Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: PR Newswire
Designed for people interested in improving their overall health and wellnessProvides real-time glucose data and personal coaching insights based on the body's reaction to nutrition, exercise and life's daily stressorsAvailable without a prescription; explore different purchase options at www.hellolingo.com ABBOTT PARK, Ill., Sept. 5, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a mobile app designed for consumers who want to improve their overall health and wellness. Lingo is based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally1."There is a great deal of interest in tracking biomarkers that provide insights into one's health and wellness that were previously undetectable using the trackers available to consumers,"
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- United States Cardiovascular Surgery Devices Market Outlook to 2033: Focus on Beating Heart Surgery Systems and Perfusion Disposables [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Calculating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT) [Yahoo! Finance]Yahoo! Finance
- Pacemaker Devices Market Size to Reach USD 6.9 Billion by 2034, Driven by Minimally Invasive Techniques and Personalized Medicine | Transparency Market Research Inc. [Yahoo! Finance]Yahoo! Finance
- Home Blood Testing Devices Market to Grow by USD 2.96 Billion from 2024-2028, Driven by Disease Outbreaks, AI's Impact on the Market Landscape - Technavio Report [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/4/24 - Form 4
- ABT's page on the SEC website